28.12
전일 마감가:
$27.93
열려 있는:
$26.91
하루 거래량:
1.10M
Relative Volume:
1.40
시가총액:
$801.47M
수익:
-
순이익/손실:
$-69.47M
주가수익비율:
-5.0239
EPS:
-5.5973
순현금흐름:
$-73.92M
1주 성능:
-9.15%
1개월 성능:
-42.57%
6개월 성능:
-5.18%
1년 성능:
-1.55%
Lenz Therapeutics Inc Stock (LENZ) Company Profile
명칭
Lenz Therapeutics Inc
전화
858-925-7000
주소
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
LENZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
LENZ
Lenz Therapeutics Inc
|
28.10 | 845.46M | 0 | -69.47M | -73.92M | -5.5973 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.33 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
627.97 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.26 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.34 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.74 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-14 | 재개 | Piper Sandler | Overweight |
| 2025-03-18 | 개시 | TD Cowen | Buy |
| 2024-09-27 | 개시 | Raymond James | Outperform |
| 2024-08-12 | 개시 | H.C. Wainwright | Buy |
| 2024-04-15 | 개시 | Leerink Partners | Outperform |
| 2024-04-15 | 개시 | William Blair | Outperform |
| 2024-04-10 | 개시 | Citigroup | Buy |
| 2024-03-27 | 개시 | Piper Sandler | Overweight |
| 2023-02-23 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-02-23 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2023-02-23 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2023-01-25 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-01-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-01-06 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-06 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-04-14 | 개시 | BTIG Research | Buy |
| 2022-03-22 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-02-18 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-07-20 | 개시 | Morgan Stanley | Overweight |
| 2021-07-20 | 개시 | SVB Leerink | Outperform |
모두보기
Lenz Therapeutics Inc 주식(LENZ)의 최신 뉴스
LENZ Therapeutics Q3 2025 Earnings Preview - MSN
LENZ Therapeutics Inc (LENZ) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance
How interest rate cuts could boost LENZ Therapeutics Inc. stockIndex Update & Consistent Growth Equity Picks - newser.com
How LENZ Therapeutics Inc. stock reacts to oil pricesWeekly Risk Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Can LENZ Therapeutics Inc. stock maintain operating marginsJuly 2025 Volume & Consistent Growth Equity Picks - newser.com
Is LENZ Therapeutics Inc. stock ready for a breakoutTrade Entry Report & Safe Capital Growth Plans - newser.com
Analyzing drawdowns of LENZ Therapeutics Inc. with statistical toolsMarket Sentiment Review & Long-Term Growth Plans - newser.com
Tools to assess LENZ Therapeutics Inc.’s risk profileWeekly Profit Analysis & Real-Time Chart Pattern Alerts - newser.com
Why LENZ Therapeutics Inc. stock is trending among retail tradersWeekly Trend Summary & Weekly Breakout Watchlists - newser.com
Ranking LENZ Therapeutics Inc. among high performing stocks via toolsDay Trade & Daily Technical Stock Forecast Reports - newser.com
Has LENZ Therapeutics Inc. formed a bullish divergenceJuly 2025 Gainers & Weekly Sector Rotation Insights - newser.com
Why LENZ Therapeutics Inc. stock remains on watchlistsJuly 2025 Levels & High Accuracy Buy Signal Tips - newser.com
Chart overlay techniques for tracking LENZ Therapeutics Inc.Insider Selling & Stock Portfolio Risk Management - newser.com
Is LENZ Therapeutics Inc. trending in predictive chart modelsJuly 2025 Decliners & Weekly Top Performers Watchlists - newser.com
How LENZ Therapeutics Inc. stock reacts to Fed rate cutsMarket Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com
Combining price and volume data for LENZ Therapeutics Inc.Day Trade & AI Driven Stock Price Forecasts - newser.com
Real time scanner hits for LENZ Therapeutics Inc. explainedJuly 2025 Selloffs & Real-Time Volume Analysis - newser.com
Published on: 2025-11-03 03:22:46 - newser.com
What does recent volatility data suggest for LENZ Therapeutics Inc.Buy Signal & Community Verified Trade Alerts - newser.com
What risks investors should watch in LENZ Therapeutics Inc. stockJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com
Signal strength of LENZ Therapeutics Inc. stock in tech scannersWeekly Stock Analysis & Real-Time Buy Zone Alerts - newser.com
Will LENZ Therapeutics Inc. continue its uptrendJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
Analyzing net buyer seller activity in LENZ Therapeutics Inc.2025 Major Catalysts & Fast Gain Swing Trade Alerts - newser.com
Is LENZ Therapeutics Inc. stock a buy in volatile marketsWeekly Trade Report & Low Risk High Reward Trade Ideas - newser.com
Will LENZ Therapeutics Inc. stock see PE expansionWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com
How LENZ Therapeutics Inc. stock trades before earningsPortfolio Gains Report & High Win Rate Trade Alerts - newser.com
Lenz Therapeutics Inc (LENZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lenz Therapeutics Inc 주식 (LENZ) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Versant Venture Capital VI, L. | 10% Owner |
Sep 30 '25 |
Sale |
46.01 |
92,030 |
4,234,695 |
764,127 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 18 '25 |
Sale |
42.23 |
90,654 |
3,828,632 |
1,183,543 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 18 '25 |
Sale |
42.23 |
44,650 |
1,885,724 |
856,157 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 25 '25 |
Sale |
39.54 |
52,419 |
2,072,738 |
1,321,640 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 26 '25 |
Sale |
39.01 |
47,443 |
1,850,891 |
1,274,197 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 22 '25 |
Sale |
40.15 |
26,161 |
1,050,392 |
1,374,059 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 25 '25 |
Sale |
39.54 |
25,818 |
1,020,888 |
924,175 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 26 '25 |
Sale |
39.01 |
23,368 |
911,655 |
900,807 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 22 '25 |
Sale |
40.15 |
12,885 |
517,356 |
949,993 |
| Versant Venture Capital VI, L. | 10% Owner |
Aug 15 '25 |
Sale |
39.50 |
145,051 |
5,729,514 |
1,430,848 |
자본화:
|
볼륨(24시간):